Key facts
- This page summarizes Mary L. Schapiro's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 May 2024, 17:42.
Mary L. Schapiro - 16 May 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- Director
- Issuer ticker
- CVS
- Reported as of
- 16 May 2024
- Net transaction value
- +$167,500
- SEC form
- 4
- Accepted by SEC
- 17 May 2024, 17:42:52 UTC
- Prior SEC filing
- 17 Nov 2023
- Next SEC filing
- 03 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mary L. Schapiro
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mary L. Schapiro filed Form 4 for CVS HEALTH Corp (CVS) on 17 May 2024.
Change
- Previous filing in this sequence was filed on 17 Nov 2023.
- Current net transaction value: +$167,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 11,844
- Date
- 16 May 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
transaction
Derivative
Share Credits
Award
- Transaction value
- $167,500
- Shares
- +2,912
- Change %
- +16%
- Price
- $57.52
- Shares after
- 21,017
- Date
- 16 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,912
- Exercise price
- $0.000000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
Footnote F2
Consists of deferred stock compensation payable pursuant to Reporting Person's election.